[1]
S. . Subedi, N. . Bahadur Dangi, and A. . Bhattarai, “Adverse Drug Reactions of Potential Antiviral Drugs under Evaluation for the Treatment of COVID-19: Analysis of WHO Global Pharmacovigilance Database”, NIJOPHASR, vol. 10, no. 3, pp. 17–22, Sep. 2021.